Latest formulary decision guides
-
Formulary decision guideSemglee® ▼ (insulin glargine biosimilar)
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mylan Ltd in a format developed by Guidelines in Practice. View prescribing information here Key points
-
Formulary decision guide
Spiriva® Respimat® (tiotropium)
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Boehringer Ingelheim Limited in a format developed by Guidelines in Practice. Boehringer Ingelheim Limited reviewed the content for compliance with the ABPI code of
-
Formulary decision guide
Formulary decision guide: Ozempic®▼ (semaglutide)
Information intended for healthcare professionals only. This formulary decision guide was developed from content supplied by Novo Nordisk in a format developed by Guidelines in Practice. It has been reviewed by Novo Nordisk, who commissioned the development of the formulary decision guide. Download
-
Formulary decision guide
Formulary decision guide: Hulio® ▼ (adalimumab biosimilar)
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mylan Ltd in a format developed by Guidelines in Practice. It has been reviewed by a medicines management professional. View prescribing information here
-
Formulary decision guide
Formulary decision guide: Peptac® (sodium bicarbonate, sodium alginate, calcium carbonate)
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Teva UK Limited in a format developed by Guidelines in Practice. It has been reviewed by a medicines management professional. Click here to visit the Teva Spotlight resource
-
Formulary decision guide
Formulary decision guide: Sondate® XL (quetiapine fumarate) prolonged-release tablets
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Teva UK Limited in a format developed by Guidelines in Practice. It has been reviewed by a member of the Guidelines in Practice editorial board. Click here to visit the Teva
-
Formulary decision guide
Formulary decision guide: Monomil® XL (isosorbide mononitrate) prolonged release tablets
Information intended for healthcare professionals only. This formulary decision guide was developed from content supplied by Teva UK Limited in a format developed by Guidelines in Practice. Prescribing information can be found on page 2 of the formulary decision guide. Click here to visit the Teva
-
Formulary decision guide
Formulary decision guide: Gazylan XL® 8 mg, 16 mg, 24 mg health prolonged‐release capsules (galantamine XL)
Commissioned by Teva UK Limited
-
Formulary decision guide
Formulary decision guide: Jardiance®▼ (empagliflozin) film-coated tablets
Information intended for healthcare professionals only. This formulary decision guide was initiated, funded, and reviewed by Boehringer Ingelheim Limited and Lilly Diabetes Alliance. The format was developed by Guidelines in Practice. Prescribing information can be found on page 2 of the formulary
-
Formulary decision guide
Formulary decision guide: Combisal® (salmeterol/fluticasone) pMDI
Commissioned by Aspire Pharma Ltd
